lofexidine: Clinical Trials

18 trials of lofexidine, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

15 completed, 1 active not recruiting, 1 terminated, 1 withdrawn. 18 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 118Completed 15, Active not recruiting 1, Terminated 1, Withdrawn 1
Phase 21Active not recruiting 1

Follow lofexidine: new trials by email Literature Review of lofexidine trials Research Report on lofexidine

Trials (filtered) newest first · largest first

All 18 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Pharmacokinetic, Safety, and Tolerability Study of LUCEMYRA in the Treatment of Opioid Withdrawal Management in Adolescent Subjects
LUCEMYRA (lofexidine) tablets - Opioid Withdrawal (Disorder), Opioid Use Disorder
Phase 1WithdrawnUSWM, LLC (dba US WorldMeds)2025-06-012025-08-01
Sublingual Dexmedetomidine for Treating Opioid Withdrawal
BXCL501 (180 micrograms), BXCL501 (240 micrograms), Placebo - Opioid Use Disorder, Opioid Withdrawal
Phase 1 / Phase 2Active not recruitingNew York State Psychiatric Institute1602023-02-282026-10-28
A Study Evaluating the Relative Bioavailability of Lofexidine Granules for Reconstitution Compared to LUCEMYRA (Lofexidine) Tablets and the Effect of Food on the Bioavailability of the Lofexidine Granules for Reconstitution
Lofexidine (granules for reconstitution), LUCEMYRA (lofexidine) tablets - Normal Healthy Volunteers
Phase 1CompletedUSWM, LLC (dba US WorldMeds)162021-02-162022-06-15
Lofexidine Pharmacokinetics in the Presence of Paroxetine in Healthy Volunteers
Lofexidine, Paroxetine - Healthy
Phase 1CompletedUSWM, LLC (dba US WorldMeds)242016-01-012018-02-23
Assessment of the Effect of Naltrexone on Lofexidine Single Dose Pharmacokinetics in Healthy Subjects
Lofexidine + Naltrexone - Healthy
Phase 1CompletedUSWM, LLC (dba US WorldMeds)252015-05-012017-10-26
Single-dose Pharmacokinetics and Safety of Oral Lofexidine in Renally-Impaired Subjects
lofexidine HCl - Renally Impaired Subjects
Phase 1CompletedUSWM, LLC (dba US WorldMeds)162014-11-012017-10-26
Single-Dose Pharmacokinetics and Safety of Oral Lofexidine in Hepatically-Impaired Subjects
Lofexidine Hydrochloride (HCl) tablets - Liver Failure
Phase 1CompletedUSWM, LLC (dba US WorldMeds)242014-06-012018-02-23
Pharmacokinetic & Pharmacodynamic Interaction of Lofexidine and Buprenorphine in Buprenorphine Maintained Patients
Lofexidine HCl, Lofexidine-matching sugar pill - Opioid Dependence, Buprenorphine Withdrawal Syndrome
Phase 1CompletedUSWM, LLC (dba US WorldMeds)302013-03-012018-02-23
Main Study of Lofexidine and Methadone Pharmacodynamic Interaction in Methadone Maintained Patients
Lofexidine HCl, Lofexidine-matching sugar pill - Opioid Dependence, Methadone Withdrawal Syndrome
Phase 1CompletedUSWM, LLC (dba US WorldMeds)272012-07-012017-10-26
Lofexidine Mass Balance in Volunteers
Lofexidine hydrochloride - Normal Healthy Volunteers
Phase 1CompletedUSWM, LLC (dba US WorldMeds)62012-05-012017-10-26
Pilot Study of Lofexidine and Methadone Pharmacodynamic Interaction in Methadone Maintained Patients
Lofexidine HCl - Opioid Dependence, Methadone Withdrawal Syndrome
Phase 1CompletedUSWM, LLC (dba US WorldMeds)62012-02-012018-02-23
Lofexidine Food Effect Study in Healthy Volunteers
Lofexidine HCl - Healthy
Phase 1CompletedUSWM, LLC (dba US WorldMeds)132011-10-012018-02-23
Lofexidine ADME & Mass Balance in Volunteers
Lofexidine hydrochloride - Normal Healthy Volunteers Will be Treated With Lofexidine to Understand the Absolute Bioavailability and Mass Balance Recovery of the Product
Phase 1CompletedUSWM, LLC (dba US WorldMeds)122011-07-012017-10-26
Interactions Between Intravenous (IV) Cocaine and Lofexidine
Lofexidine, Placebo - Cocaine Related Disorders
Phase 1TerminatedNational Institute on Drug Abuse (NIDA)162010-08-012017-01-11
Effectiveness of Naltrexone and Lofexidine in Treating Detoxified Heroin Addicts - 1
Lofexidine - Heroin Dependence
Phase 1CompletedNational Institute on Drug Abuse (NIDA)2003-03-012017-01-12
Evaluation of Lofexidine for Treatment of Opioid Withdrawal - 3
Lofexidine - Opioid-Related Disorders, Substance-Related Disorders
Phase 1CompletedNational Institute on Drug Abuse (NIDA)1996-07-012017-01-12
Evaluation of Lofexidine for Treatment of Opiate Withdrawal - 10
Lofexidine - Opioid-Related Disorders
Phase 1CompletedNational Institute on Drug Abuse (NIDA)1996-04-012017-01-12
Evaluation of Lofexidine for Treatment of Opioid Withdrawal - 7
Lofexidine - Opioid-Related Disorders, Substance-Related Disorders
Phase 1CompletedNational Institute on Drug Abuse (NIDA)2017-01-12

Conditions studied

Opioid-Related Disorders (8)  ·  Substance-Related Disorders (2)  ·  Cocaine-Related Disorders (1)  ·  Heroin Dependence (1)  ·  Kidney Failure, Chronic (1)  ·  Liver Failure (1)

Sponsors

USWM, LLC (dba US WorldMeds) (12)  ·  National Institute on Drug Abuse (NIDA) (5)  ·  New York State Psychiatric Institute (1)

Countries

United States (18)

Top investigators

James A Longstreth, PhD (6)  ·  Charles W Gorodetzky, MD, PhD (5)  ·  Charles O'Brien, M.D., Ph.D. (2)  ·  James Longstreth, PhD (2)  ·  Mark Leibowitz, MD (2)  ·  Thomas Marbury, MD (2)  ·  Charles Gorodetzky, MD (1)  ·  Charles Gorodetzky, MD, PhD (1)  ·  Charles W. Gorodetzky, MD, PhD (1)  ·  George Atiee, MD (1)  ·  George J Atiee, MD (1)  ·  Kim New (1)  ·  Sandra Comer, Ph.D (1)  ·  Thomas R Kosten, M.D. (1)  ·  Walter Ling, M.D. (1)

NIH funding

U01DA030916 (3), 1UG3DA061620 (1), R01DA047690 (1), U01DA033276 (1), UG3DA056247-01 (1)